Mylan Pharmaceuticals

Activities: Drug Delivery Pharmaceutical

Trending Articles

  1. RCPE and InSilicoTrials to digitalise and accelerate the development of pharmaceutical manufacturing processes RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialise the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows...
  2. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  3. AstraZeneca to progress development of Quell Therapeutics' IBD Treg AstraZeneca will now perform IND-enabling studies on the cell therapy candidate, facilitating its clinical development
  4. EU GMP Annex 1 (August 2022): impact on cleaning and disinfection Cleaning and microbial contamination control are critical focus areas in the pharmaceutical and medical device industries. Robust cleaning and disinfection programmes are...
  5. Watson-Marlow Fluid Technology Solutions launches WMArchitect Interchangeable Parts Interchangeable Parts incorporates pre-qualified, alternative components in the design stage of your single-use assembly

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

Related Content

Finance

Mylan chooses Beximco for exclusive antibody distribution in Bangladesh

Beximco Pharma has received the exclusive rights to launch Netherlands-based Mylan’s portfolio of key monoclonal antibodies in its headquarters of Bangladesh
Regulatory

Biocon biologics facility gets FDA nod

India's biopharmaceutical giant has been investing in expanding manufacturing capacity in line with expectations of higher biosimilars penetration in developed and emerging market
Finance

Pfizer and Mylan to launch new global pharmaceutical company

Upjohn, Pfizer’s off-patent branded and generic business, will merge with Mylan
Drug Delivery

Mylan and Hospira voluntarily recall injectables

Glass and copper salts were found in the companies’ injectable medications but no adverse reactions have been reported as yet
Media

Global market for inhaled drugs rapidly growing

As incidences of diseases such as COPD and asthma rise, so too does the global demand for inhaled drugs, especially those using innovative new delivery technologies
Research & Development

Mylan to acquire Renaissance's speciality and generic topical business

Mylan is acquiring the business on a cash-free, debt-free basis and expects to finance the transaction using a combination of cash and available borrowings under existing credit facilities
Regulatory

Delhi High Court puts restrictions on Biocon and Mylan breast cancer drug marketing

Court allowed the sale and manufacture of affordable cancer drugs by Biocon and Mylan with certain restrictions on packaging and labelling and regulatory process
Subscribe now